Abeona Therapeutics (NASDAQ:ABEO) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer initiated coverage on shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $19.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on ABEO. Wall Street Zen cut shares […]
Oppenheimer initiated coverage on shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $19.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on ABEO. Wall Street Zen cut shares […]
